Zdrowie i gospodarka · 03/01/2018

FDA Classifies Cervical Intraepithelial Neoplasia Test System into Class II with Special Controls

The FDA is classifying the cervical intraepithelial neoplasia (CIN) test system into Class II with special controls to ensure safety and effectiveness, aiming to reduce regulatory burdens and enhance patient access to innovative devices.